Skip to main content
. 2017 May 7;8(30):49351–49358. doi: 10.18632/oncotarget.17656

Table 3. Primers for point mutations in the B-RAF, H, K and N-RAS genes.

Gene Sequence 5′ ---> 3′ Work concentration (pmol/μl)
BRAF ex15 Forward CTCATCCTAACACATTTCAAGCC 0.4
BRAF ex15 Reverse CTATAGTTGAGACCTTCAATGACTTTC 0.4
HRAS ex2 Forward TGGCTGAGCAGGGCCCTCCT 0.2
HRAS ex2 Reverse CTGCTGGCACCTGGACGGCGGC 0.2
HRAS ex3 Forward GGCATGAGAGGTACCAGGGAGA 0.4
HRAS ex3 Reverse AGGACAGGAGGCCCCTGCCTGGAC 0.4
KRAS ex2 Forward GGTACTGGTGGAGTATTTGATAGTG 0.2
KRAS ex2 Reverse CTGACATACTCCCAAGGAAAGTAAAG 0.2
KRAS ex3 Forward TCCCTTCTCAGGATTCCTACAGG 1.2
KRAS ex3 Reverse CCCACCTATAATGGTGAATATC 1.2
NRAS ex2 Forward AGAACCAAATGGAAGGTCAC 0.2
NRAS ex2 Reverse GTGAGAGACAGGATCAGGTC 0.2
NRAS ex3 Forward TGAGGGACAAACCAGATAGGC 0.6
NRAS ex3 Reverse CTGTAGAGGTTAATATCCGCAAATG 0.6

PCR multiplex 2: Oligonucleotides used for the multiplex detection of exon 15 of the BRAF gene, point mutations in codons 12, 13 and 61 (hotspots) of the HRAS gene and in codons 12, 13, 59, 61 of K-NRAS genes. The concentration primers in the mix is reported.